findmyKOL
Clinical trialNCT00709215UnknownPhase 1/PHASE2Interventional

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

SponsorOncoVista, Inc.Enrollment44Refractory TdT-Positive Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Brigham & Women'S Hospital

    Boston, Massachusetts, United States

    Recruiting
  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

    Adriana Penicaud, PADaneil J DeAngelo, MD, PhD.Eyal Attar, MDGregory Abel, MD, MPHIlene Galinsky, APRNKaren Kuhn Ballen, MDL. Andres Sirulnik, MDMartha Wadleigh, MDPhilip Amrein, MDRichard Stone, MDSusan L Buchanan, PA
    Recruiting
  • Cancer Therapy Reasearch Center at Uthsca

    San Antonio, Texas, United States

    Alain Mita, MDMonica Mita, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2008
Primary completion
31 Dec 2010
Completion
31 Dec 2010
Last update posted
9 Jan 2009
Registered enrollment
44
Registry id
NCT00709215

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.